Patient Awareness and Expectations of Pharmacist Services During Hospital Stay.
*Anticipation; *Awareness; *Health Knowledge; 80 and over; Adolescent; Adult; Aged; Attitudes; Descriptive Statistics; Female; Health Services Accessibility; hospital; Hospital/methods/*statistics & numerical data; Human; Humans; Inpatients; Inpatients/*psychology; Male; marketing; Marketing/methods; Middle Aged; Patient Attitudes; patient awareness; Patient Education; patient expectations; Pharmacists/*statistics & numerical data; Pharmacy Service; pharmacy services; Practice; Pretest-Posttest Design; Professional Role; Professional-Patient Relations; Psychological; Social Marketing; Summated Rating Scaling; Surveys; Surveys and Questionnaires; United States; Young Adult
BACKGROUND: There are insufficient data in the United States regarding patient awareness and expectations of hospital pharmacist availability and services. OBJECTIVE: The objective of this research is to assess patient awareness and expectations of hospital pharmacist services and to determine whether a marketing campaign for pharmacist services increases patient awareness and expectations. METHODS: Eligible inpatients were surveyed before and after implementation of a hospital-wide pharmacist services marketing campaign (12 items; Likert scale of 1 [strongly disagree] to 4 [strongly agree]; maximum total score of 48) regarding awareness of pharmacist services. The primary outcome was the change in median total survey scores from baseline. Other outcomes included the frequency of patient requests for pharmacists. RESULTS: Similar numbers of patients completed the survey before and after the campaign (intervention, n = 140, vs control, n = 147). Awareness of pharmacist availability and services was increased (41 [interquartile ranges, IQRs: 36-46] vs 37 [IQR 31-43]; P \textless .001). Patients were 7 times more likely to request a pharmacist following the marketing campaign implementation. CONCLUSION: Awareness among inpatients of pharmacist services is low. Marketing pharmacist availability and services to patients in the hospital improves awareness and expectations for pharmacist-provided care and increases the frequency of patient-initiated interaction between pharmacists and patients. This could improve patient outcomes as pharmacists become more integrally involved in direct patient care.
King Philip K; Martin Steven J; Betka Eric M
Journal of pharmacy practice
2017
2017-10
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
<a href="http://doi.org/10.1177/0897190016665541" target="_blank" rel="noreferrer noopener">10.1177/0897190016665541</a>
Management of Phenobarbital and Apixaban Interaction in Recurrent Cardioembolic Stroke.
King Philip K; Stump Trevor A; Walkama Allyn M; Ash Benjamin M; Bowling Susana M
Annals of Pharmacotherapy
2018
2018-06
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
<a href="http://doi.org/10.1177/1060028018759938" target="_blank" rel="noreferrer noopener">10.1177/1060028018759938</a>
Consensus Clinical Decision-Making Factors Driving Anticoagulation in Atrial Fibrillation
Guideline-recommended anticoagulation is frequently omitted in high-risk patients with atrial fibrillation (AF) for reasons not fully understood, which may result in suboptimal care. A nationally representative, expert group of physicians (cardiology, neurology, and general medicine), and clinical pharmacists participated in a consensus-seeking, modified Delphi method to identify key clinical decision-making factors driving anticoagulant prescribing in real-world AF patients. Representing >2,500 anticoagulation-related patient encounters per month, 27 of 30 participants completed the study (90% overall response rate). In Round-1, experts rated their level of agreement with factors and suggested modifications or additional factors. Of 66 factors entering Round-1, 21 met and 4 partially met consensus, 41 did not meet consensus, and 7 were newly suggested. Of 32 factors advanced for scoring in Round-2, 16 met consensus criteria. In Round-3, experts were given the option to rescue up to 2 of the 16 nonconsensus factors from Round-2. Including a concomitant need for dual antiplatelet therapy, no factor was successfully rescued into consensus. The most important factors related to risk of infarction rather than bleeding risk or other patient-specific considerations. Among factors not independently addressed in current guidelines, these included baseline hematologic indicators of potential bleeding risk, previous bleeding episodes by specific type, other risk factors for bleeding, and adherence. In conclusion, when determining anticoagulation strategies in AF, there is a need for further research on the clinical implications of these emerging factors as well as the reasons behind divergent opinions toward nonconsensus factors.
King Philip K; Fosnight Susan M; Bishop Jeffrey R
The American Journal of Cardiology
2019
2019-07
<a href="http://doi.org/10.1016/j.amjcard.2019.07.006" target="_blank" rel="noreferrer noopener">10.1016/j.amjcard.2019.07.006</a>